electroCore (ECOR) EBT (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -103.72% |
| Dec 31, 2025 | 19.38% |
| Sep 30, 2025 | 7.25% |
| Jun 30, 2025 | 5.94% |
| Mar 31, 2025 | -147.95% |
| Dec 31, 2024 | 425.95% |
| Sep 30, 2024 | 5.95% |
| Jun 30, 2024 | 26.82% |
| Mar 31, 2024 | 1.95% |
| Dec 31, 2023 | 8.23% |
| Sep 30, 2023 | 17.76% |
| Jun 30, 2023 | 19.33% |
| Mar 31, 2023 | -29.29% |
| Dec 31, 2022 | 13.79% |
| Sep 30, 2022 | 5.69% |
| Jun 30, 2022 | -3.58% |
| Mar 31, 2022 | -147.47% |
| Dec 31, 2021 | 395.06% |
| Sep 30, 2021 | -5.45% |
| Jun 30, 2021 | 29.81% |
| Mar 31, 2021 | 14.86% |
| Dec 31, 2020 | -40.95% |
| Sep 30, 2020 | 24.12% |
| Jun 30, 2020 | 25.72% |
| Mar 31, 2020 | 6.14% |
| Dec 31, 2019 | 20.65% |
| Sep 30, 2019 | 11.68% |
| Jun 30, 2019 | 12.70% |
| Mar 31, 2019 | 9.61% |
| Dec 31, 2018 | -16.17% |
| Sep 30, 2018 | 25.76% |
| Jun 30, 2018 | -88.30% |
| Mar 31, 2018 | -64.65% |
| Dec 31, 2017 | 53.60% |
| Sep 30, 2017 | -66.38% |